Patient-care practices associated with an increased prevalence of hepatitis c virus infection among chronic hemodialysis patients

Infection Control and Hospital Epidemiology

Volumn 32, Issue 5, 2011, Pages 415-424

  Shimokura, Gayle ^a   Chai, Feng ^b   Weber, David J ^a   Samsa, Gregory P ^a   Xia, Guo liang ^b   Nainan, Omana V ^b   Tobler, Leslie H ^c   Busch, Michael P ^c   Alter, Miriam J ^b,d  

^a University of North Carolina at Chapel Hill   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL PRACTICE; DISINFECTION; DRUG USE; FEMALE; GENETIC SCREENING; HEALTH CARE FACILITY; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; NONHUMAN; PATIENT CARE; PREVALENCE; PROBABILITY; RISK FACTOR; TREATMENT DURATION; UNITED STATES;

AMBULATORY CARE FACILITIES; CROSS-SECTIONAL STUDIES; DISINFECTION; EQUIPMENT REUSE; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT CARE; PERSONNEL MANAGEMENT; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; SPECIMEN HANDLING; TIME FACTORS;

EID: 79955518180     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/659407     Document Type: Article

References (40)

1. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 2010;138:513-521.
2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-714.
3. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005;18:52-61.
4. Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat 2007;14:697-703.
5. Maluf DG, Fisher RA, King AL, et al. Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival. Transplantation 2007;83:853-857.
6. Terrault NA, Adey DB. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol 2007;2:563-575.
7. Centers for Disease Control and Prevention. Hepatitis C virus transmission at an outpatient hemodialysis unit-New York, 2001-2008. MMWR Morb Mortal Wkly Rep 2009;58:189-194.
8. Saab S, Martin P, Brezina M, Gitnick G, Yee HF Jr. Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis. Am J Kidney Dis 2001;37:308-315.
9. Thompson ND, Novak RT, Datta D, et al. Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol 2009;30:900-903.
10. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001;50:1-45.
11. Centers for Disease Control. Hepatitis: control measures for hepatitis B in dialysis centers. HEW publication no. (CDC) 78-8358 (Viral Hepatitis Investigations and Control Series). 1977.
12. Centers for Medicare and Medicaid Services. National listing of Medicare providers furnishing kidney dialysis and transplant services. Washington, DC: Government Printing Office, 2000.
13. Page-Shafer K, Pappalardo BL, Tobler LH, et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 2008;46: 499-506.
14. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984;12:387-395.
15. Cody SH, Nainan OV, Garfein RS, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002;162:345-350.
16. Felsenstein J. Estimating effective population size from samples of sequences: a bootstrap Monte Carlo integration method. Genet Res 1992;60:209-220.
17. US Renal Data System. USRDS 2001 Annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 2001.
18. Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007;28: 519-524.
19. Carducci A, Verani M, Casini B, et al. Detection and potential indicators of the presence of hepatitis C virus on surfaces in hospital settings. Lett Appl Microbiol 2002;34:189-193.
20. Froio N, Nicastri E, Comandini UV, et al. Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 2003;42:546-550.
21. Girou E, Chevaliez S, Challine D, et al. Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis 2008;47:627-633.
22. Simjanovska LJ, Porcu K, Amitov V, Efremov GD, Polenakovic M. Reverse transcriptase/polymerase chain reaction analyses of hemodialysis ultrafiltrates and sera of hepatitis C virus positive patients. Int J Artif Organs 2004;27:35-39.
23. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;1:550-551.
24. Laporte F, Tap G, Jaafar A, et al. Mathematical modeling of hepatitis C virus transmission in hemodialysis. Am J Infect Control 2009;37:403-407.
25. Savey A, Simon F, Izopet J, Lepoutre A, Fabry J, Desenclos JC. A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Control Hosp Epidemiol 2005;26: 752-760.
26. Fissell RB, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004;65:2335-2342.
27. Izopet J, Sandres-Saune K, Kamar N, et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol 2005;77:70-76.
28. Petrosillo N, Gilli P, Serraino D, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001;37:1004-1010.
29. Sivapalasingam S, Malak SF, Sullivan JF, Lorch J, Sepkowitz KA. High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center. Infect Control Hosp Epidemiol 2002;23:319-324.
30. Shimokura G, Weber DJ, Miller WC, Wurtzel H, Alter MJ. Factors associated with personal protection equipment use and hand hygiene among hemodialysis staff. Am J Infect Control 2006;34:100-107.
31. Fabrizi F, Messa P, Martin P. Transmission of hepatitis C virus infection in hemodialysis: current concepts. Int J Artif Organs 2008;31:1004-1016.
32. Delarocque-Astagneau E, Baffoy N, Thiers V, et al. Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine? Infect Control Hosp Epidemiol 2002;23:328-334.
33. Tu AW, Buxton JA, Whitlock M, et al. Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol 2009;20:e19-e23.
34. Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003;52:1-13.
35. Ghafur A, Raza M, Labbett W, et al. Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis. Nephrol Dial Transplant 2007;22:2640-2644.
36. Glynn SA, Wright DJ, Kleinman SH, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005;45:994-1002.
37. Orton SL, Stramer SL, Dodd RY, Alter MJ. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion 2004;44:275-281.
38. O'Boyle CA, Henly SJ, Larson E. Understanding adherence to hand hygiene recommendations: the theory of planned behavior. Am J Infect Control 2001;29:352-360.
39. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf. Accessed March 20, 2010.
40. Centers for Disease Control and Prevention. Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials. MMWR Morb Mortal Wkly Rep 2008;57:875-876.